Active treatment with a high dose of BGS649 + Active treatment with a low dose of BGS649 + Placebo treatment to blind study
Phase 2Completed 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Endometriosis
Conditions
Endometriosis
Trial Timeline
Jul 1, 2010 → Sep 1, 2011
NCT ID
NCT01190475About Active treatment with a high dose of BGS649 + Active treatment with a low dose of BGS649 + Placebo treatment to blind study
Active treatment with a high dose of BGS649 + Active treatment with a low dose of BGS649 + Placebo treatment to blind study is a phase 2 stage product being developed by Novartis for Endometriosis. The current trial status is completed. This product is registered under clinical trial identifier NCT01190475. Target conditions include Endometriosis.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01190475 | Phase 2 | Completed |
Competing Products
20 competing products in Endometriosis